Brief: Thalia Therapeutics Says New Patent Granted For Miristen In China
29/09/2026 07:35
BRIEF-Thalia Therapeutics Says New Patent Granted For Miristen In China Sept 29 (Reuters) - Thalia Therapeutics PLC THAT.L:
THALIA THERAPEUTICS - NEW PATENT GRANTED FOR MIRISTEN IN CHINA
THALIA THERAPEUTICS - PHASE 1 TRIAL RESULTS FOR MIRISTEN EXPECTED IN H1 2027
Source text: ID:nRSc7381Wa
Further company coverage: THAT.L
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Thalia Therapeutics
See all newsThalia Therapeutics - Interim Results
Brief: Thalia Therapeutics Says New Patent Granted For Miristen In China
Thalia Therapeutics - New Patent Granted for miRisten in China
Thalia Therapeutics - RNA gene-silencing cardiovascular program advances
Thalia Therapeutics - Business Update and Notice of Results